412077000: Adrenal hormone agent (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2467529014 Adrenal hormone agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2473681016 Adrenal hormone agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3199501000005112 binyrehormonmiddel da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
binyrehormonmiddel	Is a	Adrenal hormone	false	Inferred relationship	Some
binyrehormonmiddel	Is a	Drug allergen	false	Inferred relationship	Some
binyrehormonmiddel	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Adrenal hormone (disposition)	false	Inferred relationship	Some
binyrehormonmiddel	Is a	Hormone	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
budesonidpræparat til systemisk anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
clobetasolpropionatpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
clobetasonbutyratpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
desonidpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
diflorasondiacetatpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
desoximetasonpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
diflucortolonvaleratpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluocinolonacetonidpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluocortolonpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
flurandrenolidpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Fluticasone propionate topical preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
halcinonidpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolonacetatpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
mometasonfuroatpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
triamcinolonacetonid præparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing rimexolone in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
loteprednoletabonatpræparat til oftalmisk anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Desoxycorticosterone acetate systemic preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
betamethason 500 µg opløselig tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Betamethasone 500 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
betamethason 4 mg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Cortisone acetate 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely dexamethasone 500 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Dexamethasone 2 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Dexamethasone 100 microgram/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethason 2 mg/5 ml sukkerfri oral opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethasonnatriumphosphat 5 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethason 2 mg/5 ml flydende	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethasonphosphat 24 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethasonphosphat 4 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethasonphosphat 4 mg/ml injektionsvæske, opløsning, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Hydrocortisone 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Hydrocortisone 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortison 100 mg pulver til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortison 100 mg/ml injektionsvæske, opløsning, ampul a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortison 100 mg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortison 100 mg pulver og solvens til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolonacetat 80 mg/2 ml+ lidocainhydrochlorid 20 mg/2 ml injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolonacetat 40/1 ml + lidocainhydrochlorid 10 mg/1 ml injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolonacetat 40 mg/ml injektionsvæske, suspension, hætteglas a 3 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolon 50 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolon 50 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolon 500 mg pulver til injektionsvæske, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolon 1 g pulver til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Methylprednisolone 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Methylprednisolone 2 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Methylprednisolone 4 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Methylprednisolone 16 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolon 40 mg pulver og solvens til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolon 125 mg pulver og solvens til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolon 500 mg pulver og solvens til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolon 1 g pulver og solvens til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolon 2 g pulver og solvens til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolonacetat 40 mg/ml injektionsvæske, suspension, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolonacetat 40 mg/ml injektionsvæske, suspension, hætteglas a 2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Prednisolone 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Prednisolone 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely prednisolone 2.5 milligram/1 each gastro-resistant oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely prednisolone 5 milligram/1 each gastro-resistant oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
prednisolon 5 mg opløselig tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Prednisolone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Prednisolone 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Prednisone 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
triamcinolonacetonid 40 mg/ml injektionsvæske, suspension i fyldt injektionssprøjte a 2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
triamcinolonacetonid 40 mg/ml injektionsvæske, suspension i fyldt injektionssprøjte a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Deflazacort 6 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Deflazacort 30 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Deflazacort 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethasonnatriumphosphat 5 mg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortisonacetat 25 mg/ml injektionsvæske, suspension, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
prednisolonacetat 25 mg/ml injektionsvæske, suspension, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
triamcinolonacetonid 10 mg/ml injektionsvæske, suspension, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
triamcinolonacetonid 10 mg/ml injektionsvæske, suspension, hætteglas a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
triamcinolonacetonid 40 mg/1 ml injektionsvæske til intraartikulær/intramuskulær anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
triamcinolonhexacetonid 5 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Betamethasone sodium phosphate 1 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Clobetasone butyrate 1 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethasonnatriumphosphat 0,1 % øjendråber til engangsbrug	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethason 0,1 % + hypromellose 0,5 % øjendråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Fluorometholone 1 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Hydrocortisone acetate 5 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely hydrocortisone acetate 25 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortisonacetat 1 % øjendråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
prednisolonnatriumphosphat 0,5 % øjendråber til engangsbrug	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely rimexolone 10 milligram/1 milliliter conventional release eye drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
neomycin 0,5 % + hydrocortison 1,5 % øredråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
neomycin + hydrocortison 0,5 %/1,5 % øjen-/øredråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 50 µg vandig næsespray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonid 100 µg vandig næsespray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 50 µg vandig næsespray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 400 µg næsedråber til engangsbrug	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
triamcinolonacetonid 55 µg vandig næsespray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Tramazoline hydrochloride+dexamethasone isonicotinate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some

Start Page 2 of 9 Next End

Reference Sets

Concept inactivation indicator reference set

REPLACED BY association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2467529014	Adrenal hormone agent (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2473681016	Adrenal hormone agent	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3199501000005112	binyrehormonmiddel	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)